Patents by Inventor Yueh-Hsiung Kuo

Yueh-Hsiung Kuo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11207289
    Abstract: A method for suppressing tumor metastasis, in which an effective amount of a compound of formula (I) is administered to a subject in need thereof. Also disclosed is a method of treating cancer, in which an effective amount of a chemotherapy agent and an effective amount of a compound of formula (I) is administered to a subject in need thereof. Further disclosed are pharmaceutical compositions for suppressing tumor metastasis and for treating cancer, each of the compositions containing a compound of formula (I).
    Type: Grant
    Filed: March 17, 2017
    Date of Patent: December 28, 2021
    Assignee: ACADEMIA SINICA
    Inventors: Ning-Sun Yang, Yueh-Hsiung Kuo, Shu-Yi Yin, Yung-Hsiang Chen
  • Patent number: 11066378
    Abstract: The present invention develops a series of methyl caffeate derivatives having biological activity in anti-angiogenesis. The present invention suggests that the compounds of the invention possess inhibiting angiogenesis through regulation of VEGF/VEGFR-2 and its downstream signaling cascades in the vascular endothelial cells (VECs).
    Type: Grant
    Filed: June 4, 2015
    Date of Patent: July 20, 2021
    Assignees: Taipei Medical University, China Medical University
    Inventors: Chieh-Hsi Wu, Yueh-Hsiung Kuo, Chun-Hsu Pan
  • Publication number: 20200289454
    Abstract: A method for suppressing tumor metastasis, in which an effective amount of a compound of formula (I) is administered to a subject in need thereof. Also disclosed is a method of treating cancer, in which an effective amount of a chemotherapy agent and an effective amount of a compound of formula (I) is administered to a subject in need thereof. Further disclosed are pharmaceutical compositions for suppressing tumor metastasis and for treating cancer, each of the compositions containing a compound of formula (I).
    Type: Application
    Filed: March 17, 2017
    Publication date: September 17, 2020
    Applicants: ACADEMIA, Sinica
    Inventors: Ning-Sun Yang, Yueh-Hsiung Kuo, Shu-Yi Yin, Yung-Hsiang Chen
  • Patent number: 9744205
    Abstract: The present invention provides a method for treating breast cancer in a subject, which comprises administering to said subject an effective amount of an alcohol extract of dehulled adlay seeds. Preferably, an ethyl acetate sub-fraction of the alcohol extract of dehulled adlay seeds has a better effect in treating breast cancer.
    Type: Grant
    Filed: February 1, 2012
    Date of Patent: August 29, 2017
    Assignee: JOBEN BIO-MEDICAL CO., LTD.
    Inventors: Wenchang Chiang, Yueh-Hsiung Kuo, Yun-Lian Lin, Cheng-Pei Chung
  • Publication number: 20170216315
    Abstract: A use of an active ingredient in the manufacture of a medicament or a preparation is provided, wherein the active ingredient is at least one of ergstatrien-3?-ol and a pharmaceutically acceptable ester thereof, the medicament is for alleviating, inhibiting and/or treating the hepatic injuries caused by alcohol consumption, or for alleviating and/or inhibiting body fat accumulation caused by alcohol consumption, and the preparation is a food or a food additive for increasing the alcohol metabolism capability of the liver.
    Type: Application
    Filed: June 30, 2016
    Publication date: August 3, 2017
    Applicants: CHINA MEDICAL UNIVERSITY, NATIONAL TAIWAN UNIVERSITY
    Inventors: Yueh-Hsiung KUO, Yi-Chen CHEN, Yi-Chen LIU
  • Publication number: 20160355493
    Abstract: The present invention develops a series of methyl caffeate derivatives having biological activity in anti-angiogenesis. The present invention suggests that the compounds of the invention possess inhibiting angiogenesis through regulation of VEGF/VEGFR-2 and its downstream signaling cascades in the vascular endothelial cells (VECs).
    Type: Application
    Filed: June 4, 2015
    Publication date: December 8, 2016
    Inventors: Chieh-Hsi Wu, Yueh-Hsiung Kuo, Chun-Hsu Pan
  • Publication number: 20160151389
    Abstract: A method for inhibiting the activation of mitogen-activated protein kinase (MAPK) signaling pathway in a neuroglial cell of a subject in need, comprising administering to the subject an effective amount of an active ingredient, wherein the active ingredient is selected from a group consisting of a compound of formula (I), a pharmaceutically acceptable ester of the compound of formula (I), and combinations thereof:
    Type: Application
    Filed: March 13, 2015
    Publication date: June 2, 2016
    Inventors: Yueh-Hsiung KUO, Che-Chih HSIAO
  • Patent number: 9211244
    Abstract: A method for anti-skin aging, especially for anti-skin photo-aging in a subject is provided. The method comprising administering to the subject an effective amount of an active component selected from the group consisting of a caffeamide derivative of formula (I), a pharmaceutically acceptable salt of the caffeamide derivative, and a combination thereof: wherein A is H or an alkyl; B is —[CH2]m—; m is an integer ranging from 0 to 10; R1 is H, an optionally substituted phenyl, an optionally substituted pyridyl, —OH, or —OCH3; or, N, A, B, and R1 together form an optionally substituted pyrrolyl or piperidyl.
    Type: Grant
    Filed: October 8, 2013
    Date of Patent: December 15, 2015
    Assignee: CHINA MEDICAL UNIVERSITY
    Inventors: Hsiu-Mei Chiang, Yueh-Hsiung Kuo, Kuo-Ching Wen
  • Patent number: 9011925
    Abstract: A method for preparing polysaccharide nanocomposite particles is provided. The method comprises providing a first solution comprising an active component and a polysaccharide; adding a cross-linking agent to the first solution to provide a second solution; and allowing the second solution to conduct the reaction to form polysaccharide nanocomposite particles. The polysaccharide nanocomposite particles thus prepared show good coating ratio and enhanced applicability. Also provided is a method for inducing cancer cell apoptosis in a subject, comprising administrating to the subject an effective amount of the polysaccharide nanocomposite particles.
    Type: Grant
    Filed: October 26, 2011
    Date of Patent: April 21, 2015
    Assignee: China Medical University
    Inventors: Chih-Wei Chou, Yueh-Hsiung Kuo, Chin-Heng Yang
  • Patent number: 8945638
    Abstract: The present invention provides a method for treating gastric ulcer and/or stomach cancer in a subject, which comprises administering to said subject an effective amount of an alcohol extract of dehulled adlay seeds. Preferably, an ethyl acetate sub-fraction of the alcohol extract of dehulled adlay seeds has a better effect in treating gastric ulcer and/or stomach cancer.
    Type: Grant
    Filed: November 25, 2011
    Date of Patent: February 3, 2015
    Assignee: Joben Bio-Medical Co., Ltd.
    Inventors: Wenchang Chiang, Yueh-Hsiung Kuo, Yun-Lian Lin, Cheng-Pei Chung
  • Publication number: 20150010484
    Abstract: A method for anti-skin aging, especially for anti-skin photo-aging in a subject is provided. The method comprising administering to the subject an effective amount of an active component selected from the group consisting of a caffeamide derivative of formula (I), a pharmaceutically acceptable salt of the caffeamide derivative, and a combination thereof: wherein A is H or an alkyl; B is —[CH2]m—; m is an integer ranging from 0 to 10; R1 is H, an optionally substituted phenyl, an optionally substituted pyridyl, —OH, or —OCH3; or, N, A, B, and R1 together form an optionally substituted pyrrolyl or piperidyl.
    Type: Application
    Filed: October 8, 2013
    Publication date: January 8, 2015
    Applicant: CHINA MEDICAL UNIVERSITY
    Inventors: Hsiu-Mei CHIANG, Yueh-Hsiung KUO, Kuo-Ching WEN
  • Patent number: 8669244
    Abstract: Disclosed is a cucurbitane-triterpenoid compound for activating estrogen receptor activity, and a pharmaceutical composition, use and preparation method thereof. The cucurbitane-triterpenoid compound is presented as formula (I): wherein a single bond or a double bond is formed between C5 and C10, and a single bond or a double bond is fromed between C8 and C9; when a single bond is formed between C5 and C10, the R1 is oxygen; while a single bond is formed between C8 and C9, R2 is carbonyl group (—C?O), methyl hydroxyl group (—CH(OH)), methyl ketone or methyl dimethoxy group (—CH(OCH3)2); and wherein while R1 is oxygen (—O—) and R2 is carbonyl group (—C?O) or methyl hydroxyl group (—CH(OH)), a single bond is formed between R1 (—O—) and C19 of R2 such that R1 and R2 are formed tetrahydro-2H-pyran-2-one or hemiacetal ring.
    Type: Grant
    Filed: June 30, 2011
    Date of Patent: March 11, 2014
    Assignee: National Taiwan University
    Inventors: Ching-Jang Huang, Yueh-Hsiung Kuo, Chin Hsu
  • Patent number: 8658690
    Abstract: Disclosed herein are isolated compounds or pharmaceutically acceptable salts thereof, which exhibit immunostimulatory or anti-inflammatory effects. The compounds are isolated from the fruiting body of A. camphorata in a solid culture. Also disclosed are methods of stimulating immune responses and/or treating an inflammatory disorder with these compounds and pharmaceutical compositions including the compounds or pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: February 16, 2012
    Date of Patent: February 25, 2014
    Assignee: Well Shine Biotechnology Development Co., Ltd.
    Inventors: Yueh-Hsiung Kuo, Bi-Fong Lin
  • Patent number: 8648215
    Abstract: The present invention provides novel spiroenones extracted from an alcohol extract of dehulled adlay seeds. The present invention also provides a process for the preparation of the spiroenones and a method for treating breast cancer in a subject, which method comprises administering to said subject an effective amount of the spiroenone and a pharmaceutically acceptable carrier or excipient.
    Type: Grant
    Filed: February 1, 2012
    Date of Patent: February 11, 2014
    Assignee: Joben Bio-Medical Co., Ltd.
    Inventors: Wenchang Chiang, Yueh-Hsiung Kuo, Yun-Lian Lin, Cheng-Pei Chung
  • Patent number: 8633238
    Abstract: The present invention provides novel lactams extracted from an alcohol extract of dehulled adlay seeds. The present invention also provides a process for the preparation of the lactams and a method for treating breast cancer in a subject, which method comprises administering to said subject an effective amount of the lactam and a pharmaceutically acceptable carrier or excipient.
    Type: Grant
    Filed: February 1, 2012
    Date of Patent: January 21, 2014
    Assignee: Joben Bio-Medical Co., Ltd.
    Inventors: Wenchang Chiang, Yueh-Hsiung Kuo, Yun-Lian Lin, Cheng-Pei Chung
  • Publication number: 20130197097
    Abstract: The present invention provides novel spiroenones extracted from an alcohol extract of dehulled adlay seeds. The present invention also provides a process for the preparation of the spiroenones and a method for treating breast cancer in a subject, which method comprises administering to said subject an effective amount of the spiroenone and a pharmaceutically acceptable carrier or excipient.
    Type: Application
    Filed: February 1, 2012
    Publication date: August 1, 2013
    Inventors: WENCHANG CHIANG, YUEH-HSIUNG KUO, YUN-LIAN LIN, CHENG-PEI CHUNG
  • Publication number: 20130196007
    Abstract: The present invention provides a method for treating breast cancer in a subject, which comprises administering to said subject an effective amount of an alcohol extract of dehulled adlay seeds. Preferably, an ethyl acetate sub-fraction of the alcohol extract of dehulled adlay seeds has a better effect in treating breast cancer.
    Type: Application
    Filed: February 1, 2012
    Publication date: August 1, 2013
    Inventors: WENCHANG CHIANG, YUEH-HSIUNG KUO, YUN-LIAN LIN, CHENG-PEI CHUNG
  • Publication number: 20130197050
    Abstract: The present invention provides novel lactams extracted from an alcohol extract of dehulled adlay seeds. The present invention also provides a process for the preparation of the lactams and a method for treating breast cancer in a subject, which method comprises administering to said subject an effective amount of the lactam and a pharmaceutically acceptable carrier or excipient.
    Type: Application
    Filed: February 1, 2012
    Publication date: August 1, 2013
    Inventors: WENCHANG CHIANG, YUEH-HSIUNG KUO, YUN-LIAN LIN, CHENG-PEI CHUNG
  • Publication number: 20130136812
    Abstract: The present invention provides a method for treating gastric ulcer and/or stomach cancer in a subject, which comprises administering to said subject an effective amount of an alcohol extract of dehulled adlay seeds. Preferably, an ethyl acetate sub-fraction of the alcohol extract of dehulled adlay seeds has a better effect in treating gastric ulcer and/or stomach cancer.
    Type: Application
    Filed: November 25, 2011
    Publication date: May 30, 2013
    Inventors: WENCHANG CHIANG, YUEH-HSIUNG KUO, YUN-LIAN LIN, CHENG-PEI CHUNG
  • Publication number: 20130116338
    Abstract: A nanometal dispersion and a method for preparing a nanometal dispersion are provided. The method comprises the following steps: providing a first solution containing a metal ion; providing a second solution containing inulin; mixing the first solution and the second solution to provide a third solution; and providing energy to the third solution to conduct a reduction-oxidation reaction to form a nanometal therein. The produced nanometal dispersion comprises inulin and a nanometal with multimorphology.
    Type: Application
    Filed: November 4, 2011
    Publication date: May 9, 2013
    Applicant: CHINA MEDICAL UNIVERSITY
    Inventors: Chih-Wei CHOU, Ya-Hsun HOU, Yueh-Hsiung KUO, Yung-Hsiu CHEN